Novartis launches new Entresto trials in bid to boost sales
May 19, 2016 at 10:20 AM EDT
ZURICH, May 19 (Reuters) - Novartis's heart failure drug Entresto will be subjected to a battery of new trials as the Swiss drugmaker seeks to boost the medicine after a disappointing introduction.
